Epidermal cornification is preceded by the expression of a keratinocyte-specific set of pyroptosis-related genes

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Lachner, Julia ^a   Mlitz, Veronika ^a   Tschachler, Erwin ^a   Eckhart, Leopold ^a  

^a Universitatsklinik fur Dermatologie   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85037741566     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-17782-4     Document Type: Article

References (63)

1. Galluzzi, L. et al. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ. 19, 107-120 (2012).
2. Yuan, J., Najafov, A. & Py, B. F. Roles of caspases in necrotic cell death. Cell 167, 1693-1704 (2016).
3. Shi, J., Gao, W. & Shao, F. Pyroptosis: gasdermin-mediated programmed necrotic cell death. Trends Biochem. Sci. 42, 245-254 (2017).
4. Wang, Y. et al. Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin. Nature 547, 99-103 (2017).
5. Eckhart, L., Lippens, S., Tschachler, E. & Declercq, W. Cell death by cornification. Biochim. Biophys. Acta. 1833, 3471-3480 (2013).
6. Liston, A. & Masters, S. L. Homeostasis-Altering molecular processes as mechanisms of inflammasome activation. Nat. Rev. Immunol. 17, 208-214 (2017).
7. Garlanda, C., Dinarello, C. A. & Mantovani, A. The interleukin-1 family: back to the future. Immunity 39, 1003-1018 (2013).
8. Afonina, I. S., Müller, C., Martin, S. J. & Beyaert, R. Proteolytic processing of interleukin-1 family cytokines: variations on a common theme. Immunity 42, 991-1004 (2015).
9. Gahring, L. C., Buckley, A. & Daynes, R. A. Presence of epidermal-derived thymocyte activating factor/interleukin 1 in normal human stratum corneum. J. Clin. Invest. 76, 1585-1591 (1985).
10. Camp, R., Fincham, N., Ross, J., Bird, C. & Gearing, A. Potent inflammatory properties in human skin of interleukin-1 alpha-like material isolated from normal skin. J. Invest. Dermatol. 94, 735-741 (1990).
11. Nylander-Lundqvist, E. & Egelrud, T. Formation of active IL-1 beta from pro-IL-1 beta catalyzed by stratum corneum chymotryptic enzyme in vitro. Acta Derm. Venereol. 77, 203-206 (1997).
12. Aksentijevich, I. et al. An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. N. Engl. J. Med. 360, 2426-2437 (2009).
13. Marrakchi, S. et al. Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. N. Engl. J. Med. 365, 620-628 (2011).
14. D'Erme, A. M. et al. IL-36γ (IL-1F9) is a biomarker for psoriasis skin lesions. J Invest Dermatol. 135, 1025-1032 (2015).
15. Braegelmann, J. et al. Interleukin-36γ (IL-1F9) identifies psoriasis among patients with erythroderma. Acta Derm. Venereol. 96, 386-387 (2016).
16. Runkel, F. et al. The dominant alopecia phenotypes Bareskin, Rex-denuded, and Reduced Coat 2 are caused by mutations in gasdermin 3. Genomics 84, 824-35 (2004).
17. Lunny, D. P. et al. Mutations in gasdermin 3 cause aberrant differentiation of the hair follicle and sebaceous gland. J. Invest. Dermatol. 124, 615-621 (2005).
18. Tanaka, S., Mizushina, Y., Kato, Y., Tamura, M. & Shiroishi, T. Functional conservation of Gsdma cluster genes specifically duplicated in the mouse genome. G3 (Bethesda) 3, 1843-1850 (2013).
19. Ding, J. et al. Pore-forming activity and structural autoinhibition of the gasdermin family. Nature 535, 111-116 (2016).
20. Humke, E. W., Shriver, S. K., Starovasnik, M. A., Fairbrother, W. J. & Dixit, V. M. ICEBERG: A novel inhibitor of interleukin-1beta generation. Cell 103, 99-111 (2000).
21. Qin, H. et al. The caspase-1 inhibitor CARD18 is specifically expressed during late differentiation of keratinocytes and its expression is lost in lichen planus. J. Dermatol. Sci. 87, 176-182 (2017).
22. Nold, M. F. et al. IL-37 is a fundamental inhibitor of innate immunity. Nat. Immunol. 11, 1014-1022 (2010).
23. Dinarello, C. A. et al. Suppression of innate inflammation and immunity by interleukin-37. Eur. J. Immunol. 46, 1067-1081 (2016).
24. Li, B. et al. Transcriptome analysis of psoriasis in a large case-control sample: RNA-seq provides insights into disease mechanisms. J Invest Dermatol. 134, 1828-1838 (2014).
25. Strasser, B., Mlitz, V., Fischer, H., Tschachler, E. & Eckhart, L. Comparative genomics reveals conservation of filaggrin and loss of caspase-14 in dolphins. Exp. Dermatol. 24, 365-369 (2015).
26. Albalat, R. & Cañestro, C. Evolution by gene loss. Nat. Rev. Genet. 17, 379-391 (2016).
27. Pfeiffer, C. J. & Menon, G. K. Cellular ultrastructure and biochemical specializations in the cetacean epidermis, in Molecular and cell biology of marine mammals (ed. Pfeiffer, C. J.) 396-411 (Krieger Publishing Company, 2002).
28. Abbas Zadeh, S. et al. Phylogenetic profiling and gene expression studies implicate a primary role of PSORS1C2 in terminal differentiation of keratinocytes. Exp. Dermatol. 26, 352-358 (2017).
29. Bovine Genome Sequencing and Analysis Consortium, Elsik, C. G. et al. The genome sequence of taurine cattle: A window to ruminant biology and evolution. Science 324, 522-528 (2009).
30. Shi, J. et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 526, 660-665 (2015).
31. Liu, X. et al. Inflammasome-Activated gasdermin D causes pyroptosis by forming membrane pores. Nature 535, 153-158 (2016).
32. Tamura, M. et al. Members of a novel gene family, Gsdm, are expressed exclusively in the epithelium of the skin and gastrointestinal tract in a highly tissue-specific manner. Genomics 89, 618-629 (2007).
33. Kayagaki, N. et al. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature 526, 666-671 (2015).
34. de Almeida, L. et al. The PYRIN domain-only protein POP1 inhibits inflammasome assembly and ameliorates inflammatory disease. Immunity 43, 264-276 (2015).
35. Eckhart, L., Ban, J., Fischer, H. & Tschachler, E. Caspase-14: Analysis of gene structure and mRNA expression during keratinocyte differentiation. Biochem. Biophys. Res. Commun. 27, 655-659 (2000).
36. Johnston, A. et al. IL-1 and IL-36 are dominant cytokines in generalized pustular psoriasis. J. Allergy Clin. Immunol. 140, 109-120 (2017).
37. Nei, M. & Rooney, A. P. Concerted and birth-And-death evolution of multigene families. Annu. Rev. Genet. 39, 121-152 (2005).
38. Gulati, N. et al. Molecular characterization of human skin response to diphencyprone at peak and resolution phases: Therapeutic insights. J. Invest. Dermatol. 134, 2531-2540 (2014).
39. Mahil, S. K. et al. An analysis of IL-36 signature genes and individuals with IL1RL2 knockout mutations validates IL-36 as a psoriasis therapeutic target. Sci. Transl. Med. 9, 11 (2017).
40. Teng, X. et al. IL-37 ameliorates the inflammatory process in psoriasis by suppressing proinflammatory cytokine production. J. Immunol. 192, 1815-1823 (2014).
41. Fujita, H., Inoue, Y., Seto, K., Komitsu, N. & Aihara, M. Interleukin-37 is elevated in subjects with atopic dermatitis. J. Dermatol. Sci. 69, 173-175 (2013).
42. Keermann, M. et al. Expression of IL-36 family cytokines and IL-37 but not IL-38 is altered in psoriatic skin. J. Dermatol. Sci. 80, 150-152 (2015).
43. Sakabe, J. et al. Proteome analysis of stratum corneum from atopic dermatitis patients by hybrid quadrupole-orbitrap mass spectrometer. J. Allergy Clin. Immunol. 134, 957-660 (2014).
44. Oh, J. W., Chung, O., Cho, Y. S., MacGregor, G. R. & Plikus, M. V. Gene loss in keratinization programs accompanies adaptation of cetacean skin to aquatic lifestyle. Exp. Dermatol. 24, 572-573 (2015).
45. Fischer, H. et al. Holocrine secretion of sebum is a unique DNase2-dependent mode of programmed cell death. J. Invest. Dermatol. 137, 587-594 (2017).
46. Terao, C. et al. Transethnic meta-Analysis identifies GSDMA and PRDM1 as susceptibility genes to systemic sclerosis. Ann. Rheum. Dis. 76, 1150-1158 (2017).
47. Hirota, T. et al. Genome-wide association study identifies eight new susceptibility loci for atopic dermatitis in the Japanese population. Nat. Genet. 44, 1222-1226 (2012).
48. Damm, A., Giebeler, N., Zamek, J., Zigrino, P. & Kufer, T. A. Epidermal NLRP10 contributes to contact hypersensitivity responses in mice. Eur. J. Immunol. 46, 1959-1969 (2016).
49. Eisenbarth, S. C. et al. NLRP10 is a NOD-like receptor essential to initiate adaptive immunity by dendritic cells. Nature 484, 510-513 (2012).
50. Krishnaswamy, J. K. et al. Coincidental loss of DOCK8 function in NLRP10-deficient and C3H/HeJ mice results in defective dendritic cell migration. Proc. Natl. Acad. Sci. USA 112, 3056-3061 (2015).
51. Stehlik, C. et al. The PAAD/PYRIN-only protein POP1/ASC2 is a modulator of ASC-mediated nuclear-factor-kappa B and pro-caspase-1 regulation. Biochem. J. 373, 101-113 (2003).
52. Tervaniemi, M. H. et al. NOD-like receptor signaling and inflammasome-related pathways are highlighted in psoriatic epidermis. Sci. Rep. 6, 22745 (2016).
53. Watanabe, H. et al. Activation of the IL-1beta-processing inflammasome is involved in contact hypersensitivity. J. Invest. Dermatol. 127, 1956-1963 (2007).
54. Eckhart, L. et al. Identification of a novel exon encoding the amino-Terminus of the predominant caspase-5 variants. Biochem. Biophys. Res. Commun. 348, 682-688 (2006).
55. Zwicker, S. et al. Th17 micro-milieu regulates NLRP1-dependent caspase-5 activity in skin autoinflammation. PLoS One 12, e0175153 (2017).
56. Eckhart, L. et al. Identification and characterization of a novel mammalian caspase with proapoptotic activity. J. Biol. Chem. 280, 35077-35080 (2005).
57. Eckhart, L., Uthman, A., Sipos, W. & Tschachler, E. Genome sequence comparison reveals independent inactivation of the caspase-15 gene in different evolutionary lineages of mammals. Mol. Biol. Evol. 23, 2081-2089 (2006).
58. Mikolajczyk, J., Scott, F. L., Krajewski, S., Sutherlin, D. P. & Salvesen, G. S. Activation and substrate specificity of caspase-14. Biochemistry 43, 10560-10569 (2004).
59. Yamamoto-Tanaka, M. et al. Multiple pathways are involved in DNA degradation during keratinocyte terminal differentiation. Cell Death Dis. 5, e1181 (2014).
60. Denecker, G. et al. Caspase-14 protects against epidermal UVB photodamage and water loss. Nat. Cell Biol. 9, 666-674 (2007).
61. Mildner, M. et al. Gene silencing in a human organotypic skin model. Biochem. Biophys. Res. Commun. 348, 76-82 (2006).
62. Fischer, H. et al. Caspase-14 but not caspase-3 is processed during the development of fetal mouse epidermis. Differentiation 73, 406-413 (2005).
63. Corpet, F. Multiple sequence alignment with hierarchical clustering. Nucleic Acids Res. 16, 10881-10890 (1988).